Authors
Loading...
Meta-analysis reveals PTEN loss predicts higher Gleason grades and adverse clinical outcomes in prostate cancer.
Kisiel et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: